跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Amoclav - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Amoclav
Approved
STANDARD
Amoclav
Bilim Ilac San Ve Tic A.S.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
19e21d88225b5d75
Company
Bilim Ilac San Ve Tic A.S.
Type
Standard
Approval Details
Approval Id
19e21d88225b5d75
Drug Approval Philippines Name
Amoclav
Product Name
Amoclav
Registration Number
DR-XY33485
Brand Name
Amoclav
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Suspension
Dosage Strength
228.5 mg per 5 mL
Manufacturer
Bilim Ilac San Ve Tic A.S.
Importer
UNILAB, Inc.
Distributor
UNILAB, Inc.
Issuance Date
28 April 2022
Expiry Date
15 June 2027
Pharmacologic Category
Antibacterial (Penicillin Beta – Lactamase Inhibitor Combination)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
19e21d88225b5d75
Type
Standard
Back to Philippines FDA Approvals